SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Krystal Biotech, Inc. Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$20.74M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
+6.15%
quarter
Krystal Biotech, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.20M | $69.7 | 297.61K | |
| Q2 2022 | share | Increase | +42.59% | 88.89K shares | 5.65M | $65.66 | 297.61K |
| Q1 2022 | share | Decrease | -0.06% | -115 shares | -834K | $66.54 | 208.71K |
| Q4 2021 | share | Increase | +57.01% | 75.82K shares | 7.77M | $70.5 | 208.82K |
| Q3 2021 | share | Increase | +5.31% | 6.70K shares | -1.64M | $52.21 | 133.00K |
| Q2 2021 | share | Increase | +827.19% | 112.67K shares | 7.53M | $68 | 126.29K |
| Q1 2021 | share | Increase | 0.00% | 13.62K shares | 1.04M | $77.04 | 13.62K |